Woodline Partners’s Calidi Biotherapeutics CLDI Stock Holding History

Woodline Partners’s Portfolio CLDI Stock Details CLDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,333	Closed	-$4.2M	–	615
2023 Q2	$4.2M	Hold	3,333	–	–	0.05%	317
2023 Q1	$4.11M	Hold	3,333	–	–	0.06%	319
2022 Q4	$4.07M	Hold	3,333	–	–	0.06%	347
2022 Q3	$3.94M	Sell	3,333 -13,167	-80%	-$15.8M	0.06%	342
2022 Q2	$19.7M	Hold	16,500	–	–	0.32%	99
2022 Q1	$19.6M	Hold	16,500	–	–	0.33%	95
2021 Q4	$19.4M	Buy	+16,500	New	+$19.4M	0.28%	107

Other funds holding CLDI

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $417M AUM 45.61% 1-Year Est. Return

Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

Spectrum Asset Management (California) Newport Beach, California $315M AUM 19.93% 1-Year Est. Return

Red Wave Investments Dillsburg, Pennsylvania $335M AUM 15.13% 1-Year Est. Return

Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return

HRT Financial New York $26B AUM 58.22% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return